Search Browse Earnings

Citius Pharmaceuticals, Inc. — SlamSEC

Citius Pharmaceuticals, Inc.

Nasdaq:CTXR

Pharmaceutical Preparations·CRANFORD, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2013

Adj. EBITDA

-$42.0M

FY 2025

Net Income

-$33.6M

FY 2023

EPS (Diluted)

-$5.97

FY 2025

Stock Price

$0.84

+0.0%

2026-03-09

52W Range

$0.63 – $2.48

P/E Ratio

-0.1x

Market Cap

$18.9M

Cash

$3.3M

FY 2025

Total Debt

$300.2M

FY 2021

Net Debt

$296.9M

FY 2021

Enterprise Value

$315.8M

Debt / EBITDA

-7.1x

FY 2013

EV / EBITDA

-7.5x

Employees

—

CEO

Mazur Leonard L

CFO

Bartushak Jaime